Navigation Links
Oncolytics Biotech Inc. Reports Positive Interim Results of U.K. Combination REOLYSIN(R) and Carboplatin/Paclitaxel Trial
Date:4/9/2008

CALGARY, April 9 /PRNewswire-FirstCall/ - Oncolytics Biotech Inc. ("Oncolytics") (TSX:ONC, NASDAQ:ONCY) today announced positive interim results from its U.K. combination REOLYSIN(R) and carboplatin/paclitaxel trial. Dr. Kevin Harrington of The Institute of Cancer Research, London, and the principal investigator for the trial, presented the results today at The 5th Annual Conference of the British Society for Gene Therapy (BSGT) in Edinburgh, Scotland.

Four of the first eight patients treated in the study to date have a diagnosis of carcinoma of the head and neck. All three head and neck patients evaluated to date have had excellent clinical and radiological responses without appreciable toxicity. Preliminary assessment after recruitment of the first two cohorts has suggested that patients with head and neck carcinomas may represent a group of patients in whom the combination of carboplatin/paclitaxel and REOLYSIN(R) is active.

"These early results in head and neck patients are remarkable, considering the prognosis for refractory patients is generally poor," said Dr. Karl Mettinger, Chief Medical Officer for Oncolytics.

In the first cohort, the patient with head and neck cancer received 8 cycles of treatment (the maximum allowed) and achieved a clinical complete response. In the second cohort, the two patients with head and neck cancers with widespread disseminated disease have each received six cycles of treatment to date and both have achieved significant partial responses. Two of the three patients, including the patient with the clinical complete response, had previously received cisplatin/5-FU treatment and all three had previously received radiotherapy.

More information about this clinical trial, including CT scans from selected patients enrolled on the trial, can be found on the Oncolytics website at http://www.oncolyticsbiotech.com.

The primary objective of
'/>"/>

SOURCE Oncolytics Biotech Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Oncolytics Biotech Inc. Announces Issuance of 26th U.S. Patent
2. Oncolytics Biotech Inc. Announces Publication of Research on Immune Response to REOLYSIN(R) during a Phase I Clinical Trial
3. Oncolytics Biotech Inc. Collaborators to Present Reovirus Research at AACR Annual Meeting
4. Media Advisory - Oncolytics Biotech Inc. to Present at BioSquare 2008
5. Oncolytics Biotech Inc. Reports Highlights and Financial Results for 2007
6. Media Advisory - Oncolytics Biotech Inc. to Present at Bio CEO & Investor Conference
7. Oncolytics Biotech Inc. Announces Publication of Research on Combination Reovirus and Radiation Therapy
8. Oncolytics Biotech Inc. Proceeds to Full Enrolment in U.S. Phase II Sarcoma Clinical Trial
9. Oncolytics Biotech Inc. Announces Issuance of 8th Canadian Patent
10. Oncolytics Biotech Inc. Announces Publication of Research on Combination Reovirus and Cyclophosphamide Treatment
11. Oncolytics Biotech Inc. Announces Filing of Phase 1/2 Clinical Trial with REOLYSIN(R)

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/30/2009)...re-USNewswire/ -- The Michael J. Fox Foundation fo... million in total awards to six research teams wor...apies for Parkinson,s disease. The funding was awa... for Parkinson,s Disease program, made possible b...), a neuroscience-based biotechnology company. ,...
(Date:11/30/2009)...LOS ANGELES, Nov. 30 /PRNewswire-Asia-FirstCall/ -...n Board: CYXN; ,China Yongxin,Pharmaceuticals, or ...r and,retailer of pharmaceuticals in Northeastern ...n for distribution of medicines on the Essential D...ly formalized the nation,s Essential Drug,List whi...
(Date:11/30/2009).... 30 Exiqon A/S (NASDAQ OMX Copenh...cal School ICCB-Longwood Screening Facility (ICCB-...ter of Excellence. ICCB-L supports investigators ...s and institutions, for high-throughput screening ...NAs are a novel class of small, non-coding RNA spe...
(Date:11/28/2009)...tional Advisory Committee on Climate Change (NACCC...Project in collaboration with the Vanuatu Meteorol...d have generated preliminary climate change and se... for the country’s SNC reporting to the Unit...(UNFCCC). , Port Vila, V...
Breaking Biology Technology:The Michael J. Fox Foundation Announces $1.5 Million in Funding to Advance Development of Drug Targets for Disease-Modifying Parkinson's Disease Treatments 2The Michael J. Fox Foundation Announces $1.5 Million in Funding to Advance Development of Drug Targets for Disease-Modifying Parkinson's Disease Treatments 3China Yongxin Pharmaceuticals Inc. to Distribute Medicines on the Essential Drug List 2China Yongxin Pharmaceuticals Inc. to Distribute Medicines on the Essential Drug List 3Exiqon Recognizes Harvard Medical School Core Facility as MicroRNA Screening Center of Excellence 2Exiqon Recognizes Harvard Medical School Core Facility as MicroRNA Screening Center of Excellence 3Preliminary Climate and Sea Level Changes for Vanuatu Through the Application of SimCLIM 2Preliminary Climate and Sea Level Changes for Vanuatu Through the Application of SimCLIM 3Preliminary Climate and Sea Level Changes for Vanuatu Through the Application of SimCLIM 4
...ree Wisconsin businesses will receive funding for ... Department of Commerce under the Technology Assis...rants of up to $15,000 to early-stage Wisconsin hi...al services. The latest group of grant recipients ...laire; Micrablate, LLC, Middleton; and Neurognost...
...oving past the balkanization of information techno...ith vendors, said presenters at the Digital Healt...rily reluctant to be pushed around a bit by inform...IT problem: buy or build? After peering out at a p...reeing to standards, many institutions develop the...
...im Doyle told a gathering of health professionals ...he governor of the first state to have a fully int...ll need their help to overcome barriers. , ,Speaki...l professionals, and IT-focused health professiona...e said those barriers include organizational jealo...
Other Biology Technology:Being proactive with vendors helps healthcare improve IT 2Doyle asks health professionals to overcome barriers 2Doyle asks health professionals to overcome barriers 3
(Date:11/30/2009)...rehensive review of the state of Antarctica,s clim...tem is published this week (Tuesday 1 December) by...CAR). The review - Antarctic Climate Change and t...the icy continent, identifies areas for future sci...ns that policy makers have about Antarctic melting...
(Date:11/30/2009)...iversity of Pittsburgh team overcame a major hurdl...s those that could lead to more efficient catalyst...less toxic. The researchers reported Nov. 29 in N...emperature stability in metallic nanoparticles, th...vulnerability to extreme heat. , Gtz Veser, an a...
(Date:11/30/2009)... The Journal of Experimental Biology are pleased...ional de la Recherche Scientifique (CNRS) in the U... this year,s JEB Outstanding Paper Prize. ,The p...chievement and is intended to encourage young scie...Chief, and adds that ,we truly appreciate when aut...
Breaking Biology News(10 mins):First comprehensive review of the state of Antarctica's climate 2First metallic nanoparticles resistant to extreme heat 2French scientist wins the Journal of Experimental Biology Outstanding Paper Prize 2009 2French scientist wins the Journal of Experimental Biology Outstanding Paper Prize 2009 3French scientist wins the Journal of Experimental Biology Outstanding Paper Prize 2009 4Child Care Centers Throughout Mexico Being Crucified Unjustly Says Interchildren Inc 52045 1Child Care Centers Throughout Mexico Being Crucified Unjustly Says Interchildren Inc 52045 2EngagementHealth 28R 29 Launches Comprehensive Wellness Program with Store Kraft 80 25 of Employees and Spouses Participate in Programs 52042 1EngagementHealth 28R 29 Launches Comprehensive Wellness Program with Store Kraft 80 25 of Employees and Spouses Participate in Programs 52042 2EngagementHealth 28R 29 Launches Comprehensive Wellness Program with Store Kraft 80 25 of Employees and Spouses Participate in Programs 52042 3EngagementHealth 28R 29 Launches Comprehensive Wellness Program with Store Kraft 80 25 of Employees and Spouses Participate in Programs 52042 4Doctors 3A AMA Has Sold Out Patients 26 the Profession For A Few Dollars 52039 1Doctors 3A AMA Has Sold Out Patients 26 the Profession For A Few Dollars 52039 2
...A drug effective at treating animal models of huma... dialing down the activity of a key enzyme involve...earchers have found. , "Many drugs block the funct...d Gary Glick, who is the Werner E. Bachmann Colleg...works more like a volume control, so we,re able to...
...UCSF,s Habit Abatement Clinic is testing a vaccine...nicotine away from the brain. The vaccine is desi... start smoking again. , Called NicVax, the investi...rmaceuticals to prevent and treat nicotine addicti...a smoker inhales, nicotine is carried by the blood...
...Last week Scientists of the Alfred Wegener Institu...est air pollution on record since measurements beg...ts displayed significantly increased aerosol conce...ols from eastern Europe have been transported into...cale weather situation. , Usually the air is pure...
Other Biology News:Drug dials down the energy within cells, UM researchers find 2Record air pollution above the Arctic 2
Bio-Plex Manager Version 3.0 to 4.0 Workstation Software Upgrade Kit from Bio-Rad
Human siTrio from B-Bridge International
...oxy Vitamin D kit is an enzymeimmunoassay intended...itamin D (25-OH D) and other hydroxylated metaboli...assay technology eliminates the inconvenience of s...ore facilitates automation on many ELISA processor...
Mouse Anti-Aggrecan xxPEN Monoclonal Antibody, Unconjugated, Clone BC-4 from Abcam
Biology Products: